Cargando…
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
The causative agent of the coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions and killed hundreds of thousands of people worldwide, highlighting an urgent need to develop antiviral therapies. Here we present a quantitativ...
Ejemplares similares
-
Current proteomics methods applicable to dissecting the DNA damage response
por: Muralidharan, Monita, et al.
Publicado: (2023) -
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
por: Thorne, Lucy G, et al.
Publicado: (2021) -
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
por: White, Kris M., et al.
Publicado: (2021) -
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
por: Reuschl, Ann-Kathrin, et al.
Publicado: (2021) -
Evolution of enhanced innate immune evasion by SARS-CoV-2
por: Thorne, Lucy G., et al.
Publicado: (2021)